Evidence map›Paper›PMID 32169095›Full record

ArticleMicrobiome2020

A framework for assessing 16S rRNA marker-gene survey data analysis methods using mixtures.

Nathan D Olson, M Senthil Kumar, Shan Li, Domenick J Braccia, Stephanie Hao, Winston Timp, Marc L Salit, O Colin Stine, Hector Corrada Bravo

Abstract read
In one paragraph

Article in Microbiome, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nathan D OlsonBiosystems and Biomaterials Division, National Institute of Standards and Technology, 100 Bureau Dr., Gaithersburg, 20899, MD, USA. nolson@nist.gov.
M Senthil KumarCenter for Bioinformatics and Computational Biology, University of Maryland, College Park, 8314 Paint Branch Dr., College Park, 20742, MD, USA.
Shan LiDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, 660 W. Redwood St., Baltimore, 21201, MD, USA.
Domenick J BracciaCenter for Bioinformatics and Computational Biology, University of Maryland, College Park, 8314 Paint Branch Dr., College Park, 20742, MD, USA.
Stephanie HaoDepartment of Biomedical Engineering, Johns Hopkins University, 720 Rutland Ave., Baltimore, 21205, MD, USA.
Winston TimpDepartment of Biomedical Engineering, Johns Hopkins University, 720 Rutland Ave., Baltimore, 21205, MD, USA.
Marc L SalitJoint Initiative for Metrology in Biology, 443 Via Ortega, Stanford, 94305, CA, USA.
O Colin StineDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, 660 W. Redwood St., Baltimore, 21201, MD, USA.
Hector Corrada BravoCenter for Bioinformatics and Computational Biology, University of Maryland, College Park, 8314 Paint Branch Dr., College Park, 20742, MD, USA.

Funding

Overcoming bias and unwanted variability in next generation sequencingR01HG005220 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI IRIZARRY, RAFAEL ANGEL · 2010 to 2018
$3.6M
NHGRI NIH HHS R01 HG005220
6 · The paper itself

Abstract

backgroundThere are a variety of bioinformatic pipelines and downstream analysis methods for analyzing 16S rRNA marker-gene surveys. However, appropriate assessment datasets and metrics are needed as there is limited guidance to decide between available analysis methods. Mixtures of environmental samples are useful for assessing analysis methods as one can evaluate methods based on calculated expected values using unmixed sample measurements and the mixture design. Previous studies have used mixtures of environmental samples to assess other sequencing methods such as RNAseq. But no studies have used mixtures of environmental to assess 16S rRNA sequencing.

resultsWe developed a framework for assessing 16S rRNA sequencing analysis methods which utilizes a novel two-sample titration mixture dataset and metrics to evaluate qualitative and quantitative characteristics of count tables. Our qualitative assessment evaluates feature presence/absence exploiting features only present in unmixed samples or titrations by testing if random sampling can account for their observed relative abundance. Our quantitative assessment evaluates feature relative and differential abundance by comparing observed and expected values. We demonstrated the framework by evaluating count tables generated with three commonly used bioinformatic pipelines: (i) DADA2 a sequence inference method, (ii) Mothur a de novo clustering method, and (iii) QIIME an open-reference clustering method. The qualitative assessment results indicated that the majority of Mothur and QIIME features only present in unmixed samples or titrations were accounted for by random sampling alone, but this was not the case for DADA2 features. Combined with count table sparsity (proportion of zero-valued cells in a count table), these results indicate DADA2 has a higher false-negative rate whereas Mothur and QIIME have higher false-positive rates. The quantitative assessment results indicated the observed relative abundance and differential abundance values were consistent with expected values for all three pipelines.

conclusionsWe developed a novel framework for assessing 16S rRNA marker-gene survey methods and demonstrated the framework by evaluating count tables generated with three bioinformatic pipelines. This framework is a valuable community resource for assessing 16S rRNA marker-gene survey bioinformatic methods and will help scientists identify appropriate analysis methods for their marker-gene surveys.

Indexed as

Data AnalysisAdultClinical Trials as TopicComputational BiologyFemaleGenetic MarkersHumansMaleMicrobiotaRNA, Ribosomal, 16SSequence Analysis, DNASoftwareYoung AdultGenetic MarkersRNA, Ribosomal, 16S16S rRNA geneAssessmentBioinformatic pipelineDifferential abundanceNormalization

Identifiers

PMID32169095
PMCPMC7071580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.